Navigation Links
Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Date:9/17/2009

st; the impact of weight loss on health; the treatment of patients with new mechanistic and better tolerated approaches; lorcaserin's patent coverage; and Arena's focus, strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the timing, success and cost of Arena's lorcaserin program and other of its research and development programs; results of clinical trials or preclinical studies may not be predictive of future results and top-line results are preliminary; clinical trials and studies may not proceed at the time or in the manner Arena expects or at all; Arena's ability to partner or commercialize lorcaserin or other of its compounds or programs; the timing and ability of Arena to receive regulatory approval for its drug candidates; Arena's ability to obtain additional funds; Arena's ability to obtain and defend its patents; and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

    Contact: Arena Pharmaceuticals, Inc.     Media Contact: Russo Partners

    Jack Lief
    President and CEO                        David Schull, President
                                             '/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Kalifornien, 28. August 2014 ... Start der Patientenrekrutierung für eine IDE-Pivot-Studie ... zur Beurteilung der Sicherheit und Wirksamkeit ... Aneurysmen („WEB") bekanntgegeben. Adam Arthur, MD, Dozent ... of Neurosurgery/Semmes-Murphey Clinic, und Hauptprüfarzt der ...
(Date:8/28/2014)... Californie, 28 août 2014 ... le début des inclusions des patients ... des dispositifs expérimentaux (ou étude « IDE » ... l,innocuité et l,efficacité du système WEB™ ... Adam Arthur , professeur agrégé, ...
(Date:8/28/2014)... Aug. 28, 2014 MGC Diagnostics Corporation (NasdaqCM: MGCD), ... call to discuss its financial results for the third ... call will be at 4:30 p.m. ET on Tuesday, ... for the third quarter of fiscal 2014 after the ... Participants can dial (877) 317-6789 or (412) 317-6789 ...
Breaking Medicine Technology:Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 3Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 4MGC Diagnostics Corporation to Report Third Quarter Fiscal 2014 Financial Results on Tuesday, September 9, 2014 2
... Va., April 16 Insmed Inc. (Nasdaq:,INSM), a ... it has received approval from the United Kingdom,s ... the Company,s,first clinical study for a follow-on biologic ... form of human G-CSF, is a follow-on,biologic of ...
... Activity in a Variety of Tumor Types, ... ENMD ), a clinical-stage pharmaceutical company developing,therapeutics for ... the presentation of preclinical results for two of ... given by EntreMed,scientists during two poster sessions at ...
Cached Medicine Technology:Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 4EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting 2EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting 3
(Date:8/28/2014)... 28, 2014 CMMI (Center for Medicare and ... of care to address patient needs. What does it all ... outcomes (with more provider accountability) and reduce the cost of ... involved in the care of a patient get a single ... to distribute it. If it sounds complicated, that's because it ...
(Date:8/28/2014)... San Franisco, CA (PRWEB) August 28, 2014 ... emerging marijuana business sector recently launched a “Video” ... relevant news and general information on various cannabis ... section, individuals can find an assortment of news ... marijuana-related issues and announcements. A portion of the ...
(Date:8/28/2014)... Lansdale, pA (PRWEB) August 28, 2014 ... is now available throughout the world, with large ... such services. Since laboratories differ with regard to ... times, and costs, payers may struggle to find ... testing needs. To help clients sort through these ...
(Date:8/28/2014)... Alexandria, VA (PRWEB) August 28, 2014 ... Foundation) will interview Stephen Isaacs, the chairperson, president and ... the Foundation’s Meet the Mesothelioma Experts live ... Foundation’s executive director and mesothelioma expert nurse practitioner, ... the interview will be Aduro BioTech’s experimental therapy for ...
(Date:8/28/2014)... The Foundation for Women’s Cancer ... September by alerting women to the link between obesity ... symptoms of endometrial cancer. , Endometrial cancer is ... common cancer. More than 52,600 will learn of a ... women with weight management challenges to know the early ...
Breaking Medicine News(10 mins):Health News:Med-Certification.com Expects Industry "Hiccups" with New Models for Patient Care and Reimbursement 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 3Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3Health News:Foundation for Women's Cancer Alerts Women to Link Between Obesity and Endometrial Cancer 2
... WuXi PharmaTech (Cayman),Inc. (NYSE: WX ), ... and development outsourcing company with operations in ... it has postponed its proposed,underwritten follow-on public ... ,In light of market conditions and ...
... Dayton general surgeon to lead statewide physicians, association, COLUMBUS, ... State Medical Association, Warren F. Muth, MD, FACS, became,president of ... is an honor to be able to serve as an ... challenges, but when physicians,work together, we can help put healthcare ...
... PA. With the war in Iraq in its ... care, Geisinger Health System will host a conference May ... better understand and meet the unique challenges faced by ... the conference, Combat Stress Injuries/Posttraumatic Stress Disorder: Implications for ...
... experience can be deadly, say authors of a new survey ... often underestimate their level of driving experience, putting them at ... , And while many teens recognize that drinking and driving ... distraction posed by having friends in the car. , "We ...
... May 6 CNS Response, Inc.,(OTC Bulletin ... Greenblatt, M.D.,Chief Medical Officer, Walden Behavioral Care ... a poster session at the American,Psychiatric Association ... "Referenced-EEG Guided Medication Predictions in,Treatment Refractory Eating ...
... WASHINGTON, DC, May 6 , - International ... Boosted,With AstraZeneca Support, For the first time, ... the,American Psychiatric Association,s (APA) prestigious "Young Minds in,Psychiatry" ... 161st Annual,Meeting in Washington, DC. The awards, supported ...
Cached Medicine News:Health News:WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering 2Health News:Many Teen Drivers Don't Think They're Inexperienced 2Health News:Many Teen Drivers Don't Think They're Inexperienced 3Health News:CNS Response, Inc.: Poster Session on Referenced-EEG Guided Medication to Be Presented at the American Psychiatric Association 161st Annual Meeting 2Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 2Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 3Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 4Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 5
... PulmoStar is a low cost compressor/nebuliser which offers ... the home, health centre or clinic. The SunMist ... and a simple filter change every six months., ... With Disposable Neb, 3 Prong Polarized plug With ...
... Compact Compressor provides effective therapy at an affordable ... at home or on the go and features ... same reliable operation you have come to count ... is the perfect solution for those patients seeking ...
... people with low to moderate pain in ... back syndrome, low back or failed back. ... pain, multiple back operations, unsuccessful disc surgery ... Pain Syndrome (CRPS). ,SynergyPlus+ was designed to ...
The ACMI TurboFlow 18 L and 10 L Insufflators provide rapid distention for all laparoscopic procedures. Eleven built-in safety features make insufflation reliable and dependable....
Medicine Products: